{"id":"https://openalex.org/W94334450","doi":null,"title":"Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.","display_name":"Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W94334450","mag":"94334450","pmid":"https://pubmed.ncbi.nlm.nih.gov/9597427"},"language":"en","primary_location":{"id":"pmid:9597427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9597427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031696883","display_name":"Clemens J. Troche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C J Troche","raw_affiliation_strings":["Institute for Health Economics, Medicine, and Society, University of Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Health Economics, Medicine, and Society, University of Cologne, Germany","institution_ids":["https://openalex.org/I180923762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079450788","display_name":"J. Tacke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Tacke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053114965","display_name":"Birte Hinzpeter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Hinzpeter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005661019","display_name":"Marion Danner","orcid":"https://orcid.org/0000-0002-0653-4092","observed_orcids":["https://orcid.org/0000-0002-0653-4092"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Danner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025752482","display_name":"Karl W. Lauterbach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K W Lauterbach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5021,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.89899244,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"19 Suppl C","issue":null,"first_page":"C59","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8916000127792358,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8916000127792358,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.09160000085830688,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14212","display_name":"Health Promotion and Cardiovascular Prevention","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.878000020980835},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.9520000219345093},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9990000128746033},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.8190000057220459},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9516377449035645},{"id":"https://openalex.org/C3019417119","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Secondary prevention","level":2,"score":0.6949130296707153},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.6713190674781799},{"id":"https://openalex.org/C2993857929","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Primary prevention","level":3,"score":0.6470571756362915},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5318419933319092},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.49418213963508606},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.47979170083999634},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.4426461458206177},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4341679513454437},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.32518666982650757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20223599672317505},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.13664808869361877},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9597427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9597427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Journal Article"},{"id":"mag:94334450","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9597427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W144965611","https://openalex.org/W1841146742","https://openalex.org/W1965253461","https://openalex.org/W2066589519"],"related_works":["https://openalex.org/W2066457780","https://openalex.org/W270699320","https://openalex.org/W2463751908","https://openalex.org/W2151920038","https://openalex.org/W4240967252","https://openalex.org/W2157841475","https://openalex.org/W2336752160","https://openalex.org/W2285054962","https://openalex.org/W2083059885","https://openalex.org/W2075536943"],"abstract_inverted_index":{"UNLABELLED:":[0],"INTRODUCTION,":[1],"AIMS,":[2],"AND":[3,112],"METHODS:":[4],"Industrial":[5],"countries'":[6],"societies":[7],"are":[8,49],"challenged":[9],"to":[10,29,43,52,153,179,189],"counter":[11],"the":[12,31,101,105,176],"increasing":[13],"costs":[14],"of":[15,20,35,62,64,74,94,96,104,132,145,162],"health":[16,57],"care.":[17],"The":[18,143],"preponderance":[19],"cardiovascular":[21],"diseases":[22],"in":[23,77,86,147,171,193],"middle-aged":[24],"people":[25],"demands":[26],"new":[27],"strategies":[28],"reduce":[30],"extremely":[32],"high":[33,183],"rates":[34],"early":[36],"deaths":[37],"and":[38,41,79,126],"increased":[39],"morbidity":[40],"thus":[42],"avert":[44],"considerable":[45],"costs.":[46],"Prevention":[47],"programmes":[48],"appropriate":[50],"means":[51],"combine":[53],"therapeutic":[54],"needs":[55],"with":[56,82,116,158,173],"economic":[58,65],"goals.":[59],"A":[60],"review":[61],"techniques":[63],"evaluation":[66],"is":[67,108,120],"given,":[68],"from":[69],"which":[70],"a":[71,129,159],"critical":[72],"appraisal":[73],"cost-effectiveness":[75,95,130,160],"analyses":[76],"primary":[78,97,148],"secondary":[80,141],"prevention":[81,98,149,187],"HMG-CoA":[83,117],"reductase":[84,118],"inhibitors":[85,119],"coronary":[87],"heart":[88],"disease":[89],"follows.":[90],"Our":[91],"own":[92],"analysis":[93],"based":[99],"on":[100],"clinical":[102],"results":[103],"WOSCOP":[106],"study":[107],"also":[109,151],"presented.":[110],"RESULTS":[111],"CONCLUSIONS:":[113],"Long-term":[114],"treatment":[115,177],"effective":[121],"(30%":[122],"mortality":[123],"reduction),":[124],"safe":[125],"tolerable.":[127],"With":[128],"ratio":[131,161],"DM15,000-25,000/life-year":[133],"saved":[134,164],"($9000-15,000)":[135],"it":[136],"can":[137],"be":[138,154,168,180,190],"recommended":[139],"for":[140,182],"prevention.":[142],"application":[144],"statins":[146],"has":[150,178],"proved":[152],"clinically":[155],"effective.":[156],"But":[157],"DM330,000/life-year":[163],"($195,000)":[165],"they":[166],"cannot":[167],"generally":[169],"advocated":[170],"patients":[172,194],"hypercholesterolaemia.":[174],"However,":[175],"considered":[181],"risk":[184,197],"patients.":[185],"Aspirin":[186],"seems":[188],"an":[191],"alternative":[192],"without":[195],"additional":[196],"factors.":[198]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}